excel pharma limited
excel pharma limited Company Information
Company Number
06887383
Next Accounts
Jun 2025
Shareholders
arif esmail
anisha esmail
Group Structure
View All
Industry
Wholesale of pharmaceutical goods
Registered Address
36 grove farm park, northwood, middlesex, HA6 2BQ
Website
-excel pharma limited Estimated Valuation
Pomanda estimates the enterprise value of EXCEL PHARMA LIMITED at £616.9k based on a Turnover of £1.3m and 0.46x industry multiple (adjusted for size and gross margin).
excel pharma limited Estimated Valuation
Pomanda estimates the enterprise value of EXCEL PHARMA LIMITED at £0 based on an EBITDA of £-257.6k and a 4.63x industry multiple (adjusted for size and gross margin).
excel pharma limited Estimated Valuation
Pomanda estimates the enterprise value of EXCEL PHARMA LIMITED at £2.3m based on Net Assets of £1.2m and 1.92x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Excel Pharma Limited Overview
Excel Pharma Limited is a live company located in middlesex, HA6 2BQ with a Companies House number of 06887383. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in April 2009, it's largest shareholder is arif esmail with a 50% stake. Excel Pharma Limited is a established, small sized company, Pomanda has estimated its turnover at £1.3m with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Excel Pharma Limited Health Check
Pomanda's financial health check has awarded Excel Pharma Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 6 areas for improvement. Company Health Check FAQs
2 Strong
2 Regular
6 Weak
Size
annual sales of £1.3m, make it smaller than the average company (£24.6m)
- Excel Pharma Limited
£24.6m - Industry AVG
Growth
3 year (CAGR) sales growth of 3%, show it is growing at a slower rate (5.3%)
- Excel Pharma Limited
5.3% - Industry AVG
Production
with a gross margin of 27.6%, this company has a comparable cost of product (27.6%)
- Excel Pharma Limited
27.6% - Industry AVG
Profitability
an operating margin of -19.3% make it less profitable than the average company (4.1%)
- Excel Pharma Limited
4.1% - Industry AVG
Employees
with 4 employees, this is below the industry average (33)
4 - Excel Pharma Limited
33 - Industry AVG
Pay Structure
on an average salary of £76.4k, the company has an equivalent pay structure (£76.4k)
- Excel Pharma Limited
£76.4k - Industry AVG
Efficiency
resulting in sales per employee of £336.4k, this is less efficient (£656.9k)
- Excel Pharma Limited
£656.9k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Excel Pharma Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 0 days, this is quicker than average (32 days)
- Excel Pharma Limited
32 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Excel Pharma Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 339 weeks, this is more cash available to meet short term requirements (10 weeks)
339 weeks - Excel Pharma Limited
10 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 1.3%, this is a lower level of debt than the average (58.4%)
1.3% - Excel Pharma Limited
58.4% - Industry AVG
EXCEL PHARMA LIMITED financials
Excel Pharma Limited's latest turnover from September 2023 is estimated at £1.3 million and the company has net assets of £1.2 million. According to their latest financial statements, Excel Pharma Limited has 4 employees and maintains cash reserves of £104.3 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Apr 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||||
| Other Income Or Grants | |||||||||||||
| Cost Of Sales | |||||||||||||
| Gross Profit | |||||||||||||
| Admin Expenses | |||||||||||||
| Operating Profit | |||||||||||||
| Interest Payable | |||||||||||||
| Interest Receivable | |||||||||||||
| Pre-Tax Profit | |||||||||||||
| Tax | |||||||||||||
| Profit After Tax | |||||||||||||
| Dividends Paid | |||||||||||||
| Retained Profit | |||||||||||||
| Employee Costs | |||||||||||||
| Number Of Employees | 4 | 4 | 4 | 4 | 4 | 4 | |||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Apr 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 3,730 | 15,983 | 21,506 | 28,890 | 10,097 | 2,653 | 1,235 | 1,222 | 1,629 | 1,266 | 1,688 | 2,250 | |
| Intangible Assets | |||||||||||||
| Investments & Other | 296,043 | 428,515 | 644,034 | 30,813 | |||||||||
| Debtors (Due After 1 year) | |||||||||||||
| Total Fixed Assets | 299,773 | 444,498 | 665,540 | 59,703 | 10,097 | 2,653 | 1,235 | 1,222 | 1,629 | 1,266 | 1,688 | 2,250 | |
| Stock & work in progress | |||||||||||||
| Trade Debtors | 229,973 | 105,204 | 498,449 | 16,425 | 214,818 | 215,168 | 202,989 | 150,425 | 200,877 | 35,377 | 65,637 | ||
| Group Debtors | 110,276 | ||||||||||||
| Misc Debtors | 823,600 | 881,275 | 792,947 | 297,315 | 112,589 | 132,250 | |||||||
| Cash | 104,278 | 216,479 | 376,591 | 1,059,179 | 595,454 | 376,180 | 85,010 | 109,044 | 87,719 | 85,825 | 54,698 | 68,675 | |
| misc current assets | |||||||||||||
| total current assets | 927,878 | 1,097,754 | 1,399,511 | 1,461,698 | 1,206,492 | 524,855 | 214,818 | 300,178 | 312,033 | 238,144 | 286,702 | 200,351 | 134,312 |
| total assets | 1,227,651 | 1,542,252 | 2,065,051 | 1,521,401 | 1,216,589 | 527,508 | 216,053 | 301,400 | 313,662 | 239,410 | 288,390 | 202,601 | 134,312 |
| Bank overdraft | |||||||||||||
| Bank loan | |||||||||||||
| Trade Creditors | 779 | 235 | 251,689 | 124,100 | 242,154 | 67,284 | 136,157 | 161,815 | 157,102 | 83,801 | 95,281 | 81,893 | |
| Group/Directors Accounts | |||||||||||||
| other short term finances | |||||||||||||
| hp & lease commitments | |||||||||||||
| other current liabilities | 15,198 | 76,489 | 356,452 | 278,178 | 330,600 | 132,171 | |||||||
| total current liabilities | 15,977 | 76,724 | 608,141 | 402,278 | 572,754 | 199,455 | 136,157 | 161,815 | 157,102 | 83,801 | 95,281 | 81,893 | |
| loans | |||||||||||||
| hp & lease commitments | |||||||||||||
| Accruals and Deferred Income | |||||||||||||
| other liabilities | 51,561 | ||||||||||||
| provisions | 3,037 | 4,086 | 5,489 | 593 | 504 | ||||||||
| total long term liabilities | 3,037 | 4,086 | 5,489 | 593 | 504 | 51,561 | |||||||
| total liabilities | 15,977 | 79,761 | 612,227 | 407,767 | 573,347 | 199,959 | 136,157 | 161,815 | 157,102 | 83,801 | 95,281 | 51,561 | 81,893 |
| net assets | 1,211,674 | 1,462,491 | 1,452,824 | 1,113,634 | 643,242 | 327,549 | 79,896 | 139,585 | 156,560 | 155,609 | 193,109 | 151,040 | 52,419 |
| total shareholders funds | 1,211,674 | 1,462,491 | 1,452,824 | 1,113,634 | 643,242 | 327,549 | 79,896 | 139,585 | 156,560 | 155,609 | 193,109 | 151,040 | 52,419 |
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Apr 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||
| Operating Profit | |||||||||||||
| Depreciation | 1,598 | 5,523 | 8,152 | 11,159 | 4,283 | 1,193 | 407 | 543 | 422 | 562 | |||
| Amortisation | |||||||||||||
| Tax | |||||||||||||
| Stock | |||||||||||||
| Debtors | -57,675 | -141,645 | 620,401 | -208,519 | 462,363 | 148,675 | -350 | 12,179 | 52,564 | -50,452 | 55,224 | 80,016 | 65,637 |
| Creditors | 544 | -251,454 | 127,589 | -118,054 | 174,870 | 67,284 | -25,658 | 4,713 | 73,301 | -11,480 | 95,281 | -81,893 | 81,893 |
| Accruals and Deferred Income | -61,291 | -279,963 | 78,274 | -52,422 | 198,429 | 132,171 | |||||||
| Deferred Taxes & Provisions | -3,037 | -1,049 | -1,403 | 4,896 | 89 | 504 | |||||||
| Cash flow from operations | |||||||||||||
| Investing Activities | |||||||||||||
| capital expenditure | |||||||||||||
| Change in Investments | -132,472 | -215,519 | 613,221 | 30,813 | |||||||||
| cash flow from investments | |||||||||||||
| Financing Activities | |||||||||||||
| Bank loans | |||||||||||||
| Group/Directors Accounts | |||||||||||||
| Other Short Term Loans | |||||||||||||
| Long term loans | |||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||
| other long term liabilities | -51,561 | 51,561 | |||||||||||
| share issue | |||||||||||||
| interest | |||||||||||||
| cash flow from financing | |||||||||||||
| cash and cash equivalents | |||||||||||||
| cash | -112,201 | -160,112 | -682,588 | 463,725 | 219,274 | 376,180 | -85,010 | -24,034 | 21,325 | 1,894 | 31,127 | -13,977 | 68,675 |
| overdraft | |||||||||||||
| change in cash | -112,201 | -160,112 | -682,588 | 463,725 | 219,274 | 376,180 | -85,010 | -24,034 | 21,325 | 1,894 | 31,127 | -13,977 | 68,675 |
excel pharma limited Credit Report and Business Information
Excel Pharma Limited Competitor Analysis
Perform a competitor analysis for excel pharma limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in HA6 area or any other competitors across 12 key performance metrics.
excel pharma limited Ownership
EXCEL PHARMA LIMITED group structure
Excel Pharma Limited has no subsidiary companies.
Ultimate parent company
EXCEL PHARMA LIMITED
06887383
excel pharma limited directors
Excel Pharma Limited currently has 2 directors. The longest serving directors include Mr Arif Esmail (Apr 2009) and Mrs Anisha Esmail (Apr 2009).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Arif Esmail | England | 62 years | Apr 2009 | - | Director |
| Mrs Anisha Esmail | United Kingdom | 62 years | Apr 2009 | - | Director |
P&L
September 2023turnover
1.3m
+5%
operating profit
-259.2k
0%
gross margin
27.7%
+4.84%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
September 2023net assets
1.2m
-0.17%
total assets
1.2m
-0.2%
cash
104.3k
-0.52%
net assets
Total assets minus all liabilities
Similar Companies
excel pharma limited company details
company number
06887383
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
incorporation date
April 2009
age
16
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
September 2023
previous names
route ahead limited (April 2020)
excel pharma limited (November 2015)
accountant
ORMEROD RUTTER LIMITED
auditor
-
address
36 grove farm park, northwood, middlesex, HA6 2BQ
Bank
NATIONAL WESTMINSTER BANK PLC
Legal Advisor
-
excel pharma limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to excel pharma limited.
excel pharma limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for EXCEL PHARMA LIMITED. This can take several minutes, an email will notify you when this has completed.
excel pharma limited Companies House Filings - See Documents
| date | description | view/download |
|---|
